a nonsignificant trendP = .289
When compared to standard-dose therapy, direct MT without thrombolysis demonstrated a nonsignificant trend toward decreased risk (aOR 0.62, 95% CI: 0.25–1.49; P = .289).
When compared to standard-dose therapy, direct MT without thrombolysis demonstrated a nonsignificant trend toward decreased risk (aOR 0.62, 95% CI: 0.25–1.49; P = .289).